2023
DOI: 10.1016/j.mcat.2023.113099
|View full text |Cite
|
Sign up to set email alerts
|

Biocatalytic asymmetric reduction of prochiral bulky-bulky ketones

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 72 publications
0
4
0
Order By: Relevance
“…The challenging aspect of asymmetric reduction for ketones with large, similar-sized groups lies in the need for the catalyst to differentiate between two groups that have subtle size differences. [19,24] Table 2 summarizes the obtained results, again both in terms of substrates conversion and ee of the obtained product.…”
Section: Hsdhs Screening For the Stereoselective Reduction Of Symmetr...mentioning
confidence: 99%
“…The challenging aspect of asymmetric reduction for ketones with large, similar-sized groups lies in the need for the catalyst to differentiate between two groups that have subtle size differences. [19,24] Table 2 summarizes the obtained results, again both in terms of substrates conversion and ee of the obtained product.…”
Section: Hsdhs Screening For the Stereoselective Reduction Of Symmetr...mentioning
confidence: 99%
“…33,34 The bioreduction of bulky and sterically demanding substrates is challenging and has been addressed by whole cell biocatalysis. 35 Recently, the bacterial whole cell reduction of sterically hindered 3,5-dioxo-5-phenylpentanoate (1) was reported by Żądło-Dobrowolska et al (Scheme 1). 36 The authors screened several species and identified stereocomplementary bacterial strains that could yield both enantiomers of 3-hydroxy-5-oxo-5-phenylpentanoates (2) and 5-hydroxy-3-oxo-5-phenylpentanoates (3).…”
Section: Bacterial Strains In Redox Biotransformationsmentioning
confidence: 99%
“…Some recent reviews have updated the application of ketoreductases in asymmetric synthesis. [15][16][17]35,105 Li et al described the use of ketoreductases including engineered enzymes that were reported between 2018 and 2020, in the asymmetric synthesis of pharmaceuticals. 15 Another recent review elaborated on the use of wild type and engineered anti-Prelog ADHs in the synthesis of optically active alcohols.…”
Section: Protein Engineering Of Carbonyl Reductasesmentioning
confidence: 99%
“…For instance, ( S )-2-chloro-1-(2′,4′-dichlorophenyl)ethanol is essential in the synthesis of ticonazole, a treatment for vaginal candidiasis and superficial fungal infections of the skin. , Similarly, ( R )-2-chloro-1-phenylethanol is used in the synthesis of mirabegron, a β-3 adrenergic receptor agonist, and ( S )-2-chloro-1-(3,4-difluorophenyl)ethanol is used in the synthesis of ticagrelor, a receptor antagonist . Optically active alcohols are typically obtained through asymmetric reduction of prochiral ketones , or via kinetic resolution (KR) or deracemization of racemates. , However, KR is limited to 50% yield with high enantiopurity, while deracemization necessitates multiple catalysts with specific stereopreferences operating in the same vessel, hampering the development of new deracemization approaches. Consequently, the asymmetric reduction of prochiral 2-haloacetophenones presents a straightforward option for producing enantiopure 2-halo-1-arylethanols.…”
Section: Introductionmentioning
confidence: 99%